Abbott and OraSure to take rapid HIV-1 test to US
This article was originally published in Clinica
Executive Summary
Abbott and OraSure Technologies are to co-market a rapid HIV-1 test in the US. Abbott will concentrate on the hospital and physician's office lab markets, while OraSure will sell mainly to the public health and criminal justice markets.